Menu
✕

Discovery of a Novel CD123 x Gamma Delta T cell Engager for the Treatment of Acute Myeloid Leukemia

FPI Press Release

92Bio, Inc. Doses First Patient in Ph1 Trial of NTB-928 in Ovarian Cancer

July 1, 2026
Discovery of a Novel CD123 x Gamma Delta T cell Engager for the Treatment of Acute Myeloid Leukemia
This website uses cookies to improve your experience. By using this website you agree to our Privacy Policy.
Read Our Terms of Use